These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2290933)

  • 1. Prevention of neural allograft rejection in the mouse following in vivo depletion of L3T4+ but not LYT-2+ T-lymphocytes.
    Nicholas MK; Chenelle AG; Brown MM; Stefansson K; Arnason BG
    Prog Brain Res; 1990; 82():161-7. PubMed ID: 2290933
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanism of rejection of MHC class I-disparate murine skin grafts. III. Are L3T4+ T cells involved in the rejection?
    Kobayashi E; Kawai K; Ikarashi Y; Watanabe H; Ito M; Fujiwara M
    Transplant Proc; 1991 Jun; 23(3):2008-11. PubMed ID: 1676551
    [No Abstract]   [Full Text] [Related]  

  • 3. Cellular pathways for rejection of class-I-MHC--disparate skin and tumor allografts.
    Smith DM; Stuart FP; Wemhoff GA; Quintáns J; Fitch FW
    Transplantation; 1988 Jan; 45(1):168-75. PubMed ID: 3276046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological rejection of grafted tissue in xenogeneic neural transplantation.
    Takei K; Nakano Y; Shinozaki T; Toya S; Tsukada Y; Kohsaka S
    Prog Brain Res; 1990; 82():103-9. PubMed ID: 1705353
    [No Abstract]   [Full Text] [Related]  

  • 5. The T cell populations mediating rejection of MHC class I disparate skin grafts in mice.
    Rosenberg AS
    Transpl Immunol; 1993; 1(2):93-9. PubMed ID: 7915953
    [No Abstract]   [Full Text] [Related]  

  • 6. T cell subsets in the thymus of graft-versus-host immunosuppressed mice. Sensitivity of the L3T4+Lyt-2- subset to cortisone.
    Kornbluth M; You-Ten E; Desbarats J; Gamache S; Xenocostas A; Lapp WS
    Transplantation; 1991 Jan; 51(1):262-7. PubMed ID: 1987697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L3T4+ cytotoxic T lymphocytes specific for class I H-2 antigens are activated in primary mixed lymphocyte reactions.
    Macphail S; Stutman O
    J Immunol; 1987 Dec; 139(12):4007-15. PubMed ID: 2961804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of T-cell subsets in rat liver allograft rejection.
    Yokoi Y; Sumimoto R; Yamaguchi A; Baba S; Nakamura S; Kimura H
    Transplant Proc; 1993 Apr; 25(2):1994-6. PubMed ID: 8470255
    [No Abstract]   [Full Text] [Related]  

  • 9. L3T4-positive T cells participate in the induction of graft-vs-host disease in response to minor histocompatibility antigens.
    Hamilton BL
    J Immunol; 1987 Oct; 139(8):2511-5. PubMed ID: 3498761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of CD4+ and CD8+ T cells in proislet allograft and xenograft rejection.
    Simeonovic CJ; Wilson JD
    Transplant Proc; 1992 Feb; 24(1):252-3. PubMed ID: 1539270
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of the L3T4+ T cell in allograft rejection.
    Hao L; Wang Y; Gill RG; Lafferty KJ
    J Immunol; 1987 Dec; 139(12):4022-6. PubMed ID: 3121726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of CD4+ and CD8+ cells in islet allo- and xeno-graft rejection.
    Gotoh M; Monden M; Yamamoto H; Kawai M; Ichikawa T; Mori T; Uenaka A; Nakayama E
    Horm Metab Res Suppl; 1990; 25():173-6. PubMed ID: 1982441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin allograft rejection by L3/T4+ and Lyt-2+ T cell subsets.
    Cobbold S; Waldmann H
    Transplantation; 1986 May; 41(5):634-9. PubMed ID: 3085299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of L3T4+ and Lyt-2+ donor cells in graft-versus-host immune deficiency induced across a class I, class II, or whole H-2 difference.
    Moser M; Sharrow SO; Shearer GM
    J Immunol; 1988 Apr; 140(8):2600-8. PubMed ID: 3258615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine cardiac allograft survival following treatment of recipients with monoclonal anti-L3T4 or Ly-2 antibodies.
    Mottram PL; Wheelahan J; McKenzie IF; Clunie GJ
    Transplant Proc; 1987 Apr; 19(2):2898-901. PubMed ID: 3105127
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of T cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class II H-2 differences. I. L3T4+ cells can either augment or retard GVHD elicited by Lyt-2+ cells in class I different hosts.
    Sprent J; Schaefer M; Gao EK; Korngold R
    J Exp Med; 1988 Feb; 167(2):556-69. PubMed ID: 2964497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effector cells in allelic H-2 class I-incompatible skin graft rejection.
    Ichikawa T; Nakayama E; Uenaka A; Monden M; Mori T
    J Exp Med; 1987 Oct; 166(4):982-90. PubMed ID: 3309129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rejection of cultured thyroid allografts by the transfer of sensitized LYT 2+ T cells.
    Warren HS; Pembrey RG
    Transplantation; 1986 Apr; 41(4):421-6. PubMed ID: 3083539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of site of transplantation and histocompatibility differences on the survival of neural tissue transplanted to the CNS of defined inbred rat strains.
    Sloan DJ; Baker BJ; Puklavec M; Charlton HM
    Prog Brain Res; 1990; 82():141-52. PubMed ID: 1981274
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of anti-L3T4 and anti-Lyt 2 monoclonal antibodies on murine cardiac allograft rejection.
    Madsen JC; Wood KJ; Morris PJ
    Transplant Proc; 1987 Oct; 19(5):3991-2. PubMed ID: 3313979
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.